0
Editorials |

What’s in a Day?

Eric B. Milbrandt, MD, MPH, FCCP; Derek C. Angus, MD, MPH, FCCP
Author and Funding Information

Affiliations: Pittsburgh, PA
 ,  Dr. Milbrandt is Assistant Professor of Critical Care Medicine, University of Pittsburgh School of Medicine. Dr. Angus is Professor of Critical Care Medicine and Health Policy and Management, University of Pittsburgh School of Medicine.

Correspondence to: Eric B. Milbrandt, MD, MPH, 641 Scaife Hall, The CRISMA Laboratory, Department of Critical Care Medicine, University of Pittsburgh, 3550 Terrace Street, Pittsburgh, PA 15261; e-mail: milbeb@ccm.upmc.edu



Chest. 2005;128(5):3091-3093. doi:10.1378/chest.128.5.3091
Text Size: A A A
Published online

Extract

Each year in the United States, there are as many as 5.6 million cases of community-acquired pneumonia (CAP), accounting for 600,000 to 1.1 million hospitalizations and $23 billion in health-care expenditures.14 Among hospitalized patients, CAP mortality rates average from 11 to 14%,5 with each case costing between $5,000 and $7,500.12 Initial treatment is empiric, directed against commonly encountered pathogens, and guided by local susceptibility patterns. Current guidelines for patients hospitalized with CAP recommend either monotherapy with a fluoroquinolone, or combination therapy with a macrolide plus either a β-lactam/β-lactamase inhibitor or third-generation cephalosporin.24 While clinical outcomes appear to be equivalent for each strategy, concerns about emerging fluoroquinolone resistance have led the Centers for Disease Control and Prevention to recommend restricting the use of fluoroquinolones to specific CAP patient groups.6 Nevertheless, the perceived increase in costs associated with a combination of drugs might lead some to choose fluororquinolone monotherapy instead.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
Antibiotics for Bacteremic Pneumonia*: Improved Outcomes With Macrolides but Not Fluoroquinolones
PubMed Articles
Guidelines
Feverish illness in children: assessment and initial management in children younger than 5 years.
National Collaborating Centre for Women's and Children's Health | 8/28/2009
Blepharitis.
American Academy of Ophthalmology | 6/5/2009
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543